The Latest Breaking News from Zimmer BioMet

Arnold Schwarzenegger, Zimmer Biomet’s first chief movement officer, wants older adults to stay active

The “Governator,” 77, is on a mission to spread the gospel of active aging.

Fortune · Nov 13, 2024

Here's What to Expect From Zimmer Biomet Holdings' Next Earnings Report

Zimmer Biomet Holdings is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings growth.

Barchart · Oct 18, 2024

Zimmer Biomet Stock: Is ZBH Underperforming the Healthcare Sector?

Zimmer Biomet has underperformed the healthcare sector over the past year, yet analysts remain moderately bullish about the stock’s prospects.

Barchart · Sep 17, 2024

Hundreds of jobs at threat at South Wales hip replacement factory

Zimmer Biomet has confirmed plans to close its factory in Bridgend

Birmingham Post · Jun 29, 2023

540 jobs at risk as Bridgend Zimmer Biomet plant set to close

Zimmer Biomet in Bridgend has entered into consultation with its staff

Wales Online · Jun 29, 2023

Masimo's (MASI) Q2 Earnings Surpass Estimates, Margins Down

Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%.

Benzinga · Aug 10, 2022

SVB Leerink Maintains Outperform Rating for Zimmer Biomet Holdings: Here's What You Need To Know

SVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE:ZBH) and raise its price target from $135.00 to $140.00. Shares of Zimmer Biomet Holdings are trading up 0.82% over the last 24 hours, at $121.67 per share.

Benzinga · May 4, 2022

Zimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates

Zimmer Biomet Holdings Inc's (NYSE:ZBH) Q1 sales increased by 3.9% Y/Y to $1.66 billion (up 6.8% on a constant currency basis), beating the consensus of $1.59 billion. Adjusted EPS was $1.61, which came in above the consensus of $1.41 and $1.55 a year ago. "We are encouraged by the better than expected results…

Benzinga · May 3, 2022